Rapilif M 50 Mg (10 Tab)

RAPILIF M 50 MG Tablet

RAPILIF M 50 MG is a prescription medication manufactured by IPCA LABORATORIES LTD, designed to manage symptoms associated with benign prostatic hyperplasia (BPH) complicated by an overactive bladder. It comes in a pack of 10 tablets.

Composition Each tablet of RAPILIF M 50 MG contains a combination of two active ingredients:

• Mirabegron: 50 mg
• Silodosin: 8 mg

Mirabegron acts as a beta-3 adrenergic receptor agonist, relaxing the bladder muscles to increase bladder capacity and reduce the urgency and frequency of urination. Silodosin is an alpha-1A adrenergic receptor antagonist, which relaxes the muscles in the prostate and bladder neck, thereby improving urine flow.

Uses RAPILIF M 50 MG is primarily used in men for the treatment of Benign Prostatic Hyperplasia (BPH) that is complicated by an overactive bladder. It helps to alleviate various lower urinary tract symptoms, including:

• Frequent urination
• Urgent need to urinate
• Difficulty starting urination
• Weak urine stream
• Incomplete bladder emptying
• Nocturia (frequent urination at night) This medication improves bladder function and comfort but does not shrink the prostate gland.

Dosage and Administration Take RAPILIF M 50 MG exactly as prescribed by your doctor. The tablet should be swallowed whole with a glass of water; do not crush, chew, or break it. It can be taken with or without food, ideally at the same time each day for optimal results. Do not take more than the prescribed dose, and do not stop the medication without consulting your doctor, as symptoms may worsen.

Side Effects Common side effects may include:

• Abnormal ejaculation (less or no noticeable semen)
• Increased heart rate
• Dizziness, including orthostatic hypotension (a drop in blood pressure upon standing)
• Nausea
• Constipation
• Urinary tract infections
• Runny or blocked nose (nasopharyngitis, nasal congestion)
• Headache
• Diarrhea
• Dry mouth
• Fatigue Most of these side effects are usually temporary and resolve over time. Consult your doctor if they persist or worsen. Serious side effects, though rare, can include swelling of the face, lips, tongue, and/or throat, causing difficulty breathing, which requires immediate medical attention. Overdose symptoms can include an increased pulse rate, systolic blood pressure, and hypotension.

Precautions

• Allergies: Do not take this medicine if you are allergic to Mirabegron, Silodosin, or any other ingredients.
• Specific Conditions: RAPILIF M 50 MG is not recommended for individuals with severe kidney disease, severe liver disease, or severe, uncontrolled high blood pressure (≥180/110 mmHg).
• Cardiac Issues: Use with caution if you have heart problems, as it may raise blood pressure and increase the risk of arrhythmias.
• Driving and Machinery: This medicine may cause dizziness, so caution is advised when driving or operating heavy machinery until you know how it affects you.
• Other Medications: Inform your doctor about all medicines you are currently taking, including over-the-counter drugs and herbal supplements, as certain medications can interact with RAPILIF M 50 MG. These include strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin), PDE5 inhibitors (e.g., sildenafil, tadalafil), and other alpha1-blockers.
• Surgery: If you are scheduled for cataract eye surgery, inform your eye specialist that you are taking this medication, as it may cause complications.
• Alcohol: Consult your doctor regarding alcohol consumption, as it may worsen certain side effects like dizziness.
• Pregnancy and Breastfeeding: This medication is not recommended for women, especially during pregnancy or breastfeeding.
• Pediatric Use: RAPILIF M 50 MG is not recommended for children and adolescents under 18 years of age.
• Geriatric Use: Older adults may be more sensitive to side effects and should use this medication under medical supervision.

Storage Store RAPILIF M 50 MG tablets in a cool and dry place, away from direct sunlight and moisture. Keep it in its original packaging at room temperature, ideally between 20°C and 25°C or below 30°C. Ensure it is kept out of reach and sight of children. Always check the expiry date and do not use the medicine past this date.

What is RAPILIF M 50 MG used for?

RAPILIF M 50 MG is primarily used in men to treat symptoms associated with Benign Prostatic Hyperplasia (BPH), which is an enlarged prostate gland. It specifically addresses BPH complicated by an overactive bladder, helping to relieve bothersome urinary symptoms such as frequent urination, urgency, a weak urine stream, difficulty starting urination, incomplete bladder emptying, and frequent urination at night (nocturia).

How does RAPILIF M 50 MG work?

RAPILIF M 50 MG contains two active ingredients: Mirabegron (50 mg) and Silodosin (8 mg). Mirabegron is a beta-3 adrenergic agonist that works by relaxing the bladder muscles, which increases the bladder's storage capacity and reduces urgent, frequent, or uncontrolled urination. Silodosin is an alpha-1A blocker that relaxes the muscles around the bladder exit and the prostate gland, making it easier to pass urine and improving urine flow. Together, these actions help to alleviate BPH symptoms.

What is the usual dosage of RAPILIF M 50 MG?

The dosage of RAPILIF M 50 MG should be taken exactly as prescribed by your doctor. It is typically taken orally, and the tablet should be swallowed whole with a glass of water, without crushing or chewing it. For optimal results, it is often recommended to take it at a fixed time each day, with or after meals. Do not exceed the prescribed dose without consulting your doctor.

What are the possible side effects of RAPILIF M 50 MG?

Common side effects may include abnormal ejaculation (less or no noticeable semen released), increased heart rate, dizziness (including dizziness when standing up, known as orthostatic hypotension), nausea, constipation, urinary tract infections, runny or blocked nose, headache, diarrhea, and dry mouth. Most of these side effects are usually temporary and resolve over time. If any side effects persist or worsen, consult your doctor.

Is RAPILIF M 50 MG safe during pregnancy or breastfeeding?

RAPILIF M 50 MG is not recommended for use in women, especially during pregnancy or while breastfeeding, as it is primarily prescribed for men with an enlarged prostate.

Can RAPILIF M 50 MG be taken with other medications?

You should inform your doctor about all medications you are currently taking to avoid potential drug interactions. RAPILIF M 50 MG may interact with strong or moderate CYP3A4 inhibitors (e.g., itraconazole, clarithromycin, diltiazem, erythromycin), phosphodiesterase-5 (PDE5) inhibitors (e.g., sildenafil, tadalafil), other alpha-blocking medications, anticholinergic medicines, cardiac glycosides (e.g., digoxin), anticoagulants (e.g., warfarin), and certain antipsychotics or antidepressants. Such interactions could increase the risk of side effects or alter the effectiveness of the medicines.

What precautions should be taken while taking RAPILIF M 50 MG?

Precautions include informing your doctor if you have allergies to Mirabegron or Silodosin. This medicine is not recommended for children and adolescents under 18 years of age. Exercise caution if you have heart problems, as it may raise blood pressure and increase the risk of arrhythmias; it is not recommended for severe uncontrolled hypertension (blood pressure ≥180/110 mmHg). Patients with severe kidney or liver impairment should avoid this medication, and those with mild to moderate impairment require caution. If you experience dizziness, avoid driving or operating heavy machinery. Inform your eye specialist if you are undergoing cataract eye surgery, as it may cause complications. It is also advisable to limit alcohol consumption while taking this medication. Geriatric patients may be more sensitive to side effects and require medical supervision.

What happens if a dose of RAPILIF M 50 MG is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

How should RAPILIF M 50 MG be stored?

RAPILIF M 50 MG should be stored in a cool, dry place, protected from direct sunlight and moisture. Keep it out of reach and sight of children. The typical recommended storage temperature is below 30°C (or between 10°C to 25°C).